Health Care News | Medical Research

Will Your Next Medication Be Created by AI?

It typically takes 10 years and $2.5 billion to bring a new drug to market. But now, scientists are using artificial intelligence (AI) to shorten the drug discovery funnel and reduce costs. What does this mean for patient access to faster and better treatments?

DocWire News spoke with Alister Campbell, vice president and global head of science and technology at Dotmatics, a company that helps researchers accelerate discoveries. Find out how innovative technology is transforming the drug discovery process and what that means for health and wellness.

Iron Supplementation Shows High Efficacy in Treating RLS in Anemia

Patrick DalyAnemia | April 26, 2024

Oral and intravenous iron supplementation effectively treated restless legs syndrome in patients with iron deficiency anemia.

Sparsentan Approved in Europe for Treatment of IgAN

Charlotte RobinsonIgAN | April 26, 2024

FILSPARI (sparsentan) has received conditional marketing authorization from the European Commission to treat IgAN in adults.

Saliva Pepsin Levels Are a Potential Risk Factor for Asthma in Children With Allergic Rhinitis

Cailin ConnerPulmonology | April 26, 2024

Research identified risk factors that may exacerbate asthma in children with allergic rhinitis.

Climbing Stairs May Prevent Cardiovascular Disease

Rob DillardESC Preventive Cardiology 2024 | April 26, 2024

Climbing stairs is associated with improved heart health and a lower risk of cardiovascular disease.

Air Pollution Linked to Depression, Heart Disease in Middle-Aged Adults

Rob DillardESC Preventive Cardiology 2024 | April 26, 2024

Air pollution is linked to stress and depression, and as a result, it puts middle-aged adults at risk of dying from CVD.

Anemia, Hyperuricemia, and Mortality Risk in Patients With CKD

Charlotte RobinsonAnemia and Kidney Disease | April 26, 2024

Researchers examined the roles of hyperuricemia and anemia in all-cause mortality with chronic kidney disease (CKD).

Study Reports Higher Prevalence of Long COVID in Men With T2D

Cailin ConnerDiabetes | April 25, 2024

Men with type 2 diabetes have higher rates of recorded long COVID.

Secondhand Smoke Exposure Significantly Increases the Risk of Atrial Fibrillation

Rob DillardAtrial Fibrillation | April 25, 2024

People who are exposed to even small amounts of secondhand smoke have a greater risk of developing atrial fibrillation.

DocWire Content Partners

CardioNerds

Gain insights from The CardioNerds, a group of cardiology experts who aim to democratize cardiovascular education.

The Fellow on Call

Fundamentals, core concepts, and important management approaches in the field of hematology and oncology

Healthcare Unfiltered

Dr. Chadi Nabhan, a renowned voice in hematology and oncology, tackles a multitude of relevant health care topics.

The Oncology Brothers

Drs. Rohit Gosain and Rahul Gosain discuss practice-changing data and standards of oncology care.

Practice Tips With Dr. Lichaa

Dr. Hady Lichaa is an interventional cardiologist specializing in complex coronary interventions.

Rheumatology Rounds With Dr. Maheswaranathan

Review important issues in the rheumatology space, including lupus, rheumatoid arthritis, and more, from Dr. Maheswaranathan.

Powered by DocWire News

GI Oncology Now is the leading medical news resource for practicing oncologists and health care providers treating gastrointestinal malignancies, offering the latest study data and research breakthroughs related to colorectal, gastric, liver, pancreatic, and esophageal cancers.

Heme Today produces the latest news and research for hematologists and oncologists focused on blood disorders such as clotting, red and white blood cell, and iron disorders, including conference highlights, late-breaking research, interviews with leaders in the field, and more.

A medical news property for practicing oncologists treating lung malignancies, Lung Cancers Today features breaking news, commentary, expert interviews, and data analysis to inform providers on the latest research and most effective clinical practices in the lung cancers space.

Nephrology Times delivers the latest news in nephrological treatments and technologies, curating content from clinical trials, conference highlights, and perspectives from key opinion leaders, with the goal of better informing care decisions and improving patient outcomes.

The Latest From GI Oncology Now

Adagrasib Plus Cetuximab Shows Promise for Patients With KRAS-Mutated Colorectal Cancer

Katy MarshallColorectal Cancer | April 24, 2024

The study’s primary end point was objective response rate determined through blinded independent central review.

LAG-3 and PD-1 Inhibitors for Esophageal and Gastroesophageal Junction Cancer: A Phase Ib Trial

Ronan Kelly, MDGastroesophageal Cancer | April 24, 2024

Dr. Ronan Kelly describes his trial on nivolumab with relatlimab for the treatment of resectable esophageal/GEJ cancer.

Combining Gemcitabine With CXCR4, PD-1 Inhibitors for Pancreatic Ductal Adenocarcinoma

Gulam Abbas Manji, MD, PhDPancreatic Cancer | April 24, 2024

Dr. Gulam A. Manji discusses CXCR4 and PD-1 inhibitors and how research has shown a potential benefit of the combination.

ARC-8: Targeting CD73 Inhibition in mPDAC With Quemliclustat and Zimberelimab

Gulam Abbas Manji, MD, PhDPancreatic Cancer | April 24, 2024

Dr. Gulam A. Manji discusses the ARC-8 study on quemliclustat plus gemcitabine/nab-paclitaxel with and without zimberelimab.

Laparoscopic Versus Laparoscopic-Assisted Gastrectomy in Gastric Cancer

Emily MenendezGastric Cancer | April 24, 2024

Surgical resection with curative intent is the primary therapy for gastric cancer, yet the 5-year survival rate is just 20%.

Lutetium Lu 177 Dotatate Approved by FDA for Pediatric GEP-NET Patients

Emily MenendezGEP-NETs | April 23, 2024

This marks the first FDA approval of a radioactive drug for patients 12 years or older with SSTER-positive GEP-NETs.

The Latest From Heme Today

Iron Supplementation Shows High Efficacy in Treating RLS in Anemia

Patrick DalyAnemia | April 26, 2024

Oral and intravenous iron supplementation effectively treated restless legs syndrome in patients with iron deficiency anemia.

Oral PK Activator Shows Sustained Safety, Efficacy in SCD

Melissa BadamoSickle Cell Disease | April 26, 2024

In the one-year, fixed-dose extension period of the ESTIMATE study, mitapivat showed continued safety and efficacy in SCD.

Oral Etavopivat Is Effective for Sickle Cell Disease Treatment in Phase I Study

Patrick DalySickle Cell Disease | April 23, 2024

Etavopivat was safe and increased hemoglobin, decreased hemolysis, and improved red blood cells in patients with SCD.

Akhila Vadivelan, MD, Discusses Iron Deposition in Transfusion-Dependent SCD

Patrick DalySickle Cell Disease | April 23, 2024

Dr. Vadivelan shared her study on pituitary and pancreatic iron deposition in patients with SCD at the 2024 ASPHO Conference.

SCD Research Lands Dr. Orkin on Time’s Most Influential People of 2024

Patrick DalySickle Cell Disease | April 19, 2024

Stuart Orkin, MD, has been named as one of Time’s 100 Most Influential People of 2024 for his work in hemoglobin research.

What Are the Health Care Resource Costs for US Pediatric Patients With SCD?

Melissa BadamoSickle Cell Disease | April 18, 2024

The study compared health care resource use and costs of pediatric patients with SCD compared with matched controls.

Expert Interviews

Network Websites

GU Oncology Now delivers the latest news in genitourinary oncology therapeutics, clinical trials, conference coverage, and research data, highlighting important advancements in treatments and technologies to better inform providers' decisions and improve patient outcomes.

Blood Cancers Today provides hematologists and oncologists with news, education, and research relevant to their patients and practices. Featuring the latest clinical updates from all facets of the specialty, it offers insights and exclusive interviews from experts in the field.

Cancer Nursing Today delivers critical news, research, and commentary to support oncology nurses throughout their education and careers. Its goal is to advance oncology treatments and care practices and promote the nurse’s role in enhanced patient outcomes and quality of life.

MashupMD is an innovative medical news and social media aggregator. The platform is optimized to deliver rapid access to the latest headlines in health care and collections of key medical content based on what health care professionals around the world are reading and sharing.

Urban Health Today is the leading independent news source that provides urban health care professionals with relevant research and policy developments that impact patients and their practices. Its coverage focuses on clinical, social, and environmental health disparities.